EX-99.4 6 tm2327944d3_ex99-4.htm EXHIBIT 99.4

 

Exhibit 99.4

 

CONSENT OF PERELLA WEINBERG PARTNERS L.P.

 

We hereby consent to the inclusion of our opinion dated October 4, 2023 appearing as Annex C to, and the reference to such opinion letter under the headings “Prospectus Summary—Opinion of SomaLogic’s Financial Advisor” and “The Merger—Opinion of SomaLogic Financial Advisor” in, the Registration Statement on Form S-4 of Standard BioTools Inc. and in the Joint Proxy Statement/Prospectus of Standard BioTools Inc. and SomaLogic, Inc., which is part of the Registration Statement, filed on November 13, 2023 (the “Registration Statement”). In giving the foregoing consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Securities Act”), or the rules and regulations promulgated thereunder, nor do we admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “experts” as used in the Securities Act or the rules and regulations promulgated thereunder. Additionally, such consent does not cover any future amendments to the Registration Statement.

 

PERELLA WEINBERG PARTNERS LP

 

/s/ Perella Weinberg Partners LP

 

New York, New York

 

November 13, 2023